Published in
Wiley, European Journal of Heart Failure, 10(24), p. 1805-1812, 2022
DOI: 10.1002/ejhf.2670
Links
Tools
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial
Journal article published in 2022 by
Kelley R. H. Branch 
,
Gilles R. Dagenais ,
Alvaro Avezum ,
Jan Basile ,
Ignacio Conget ,
William C. Cushman ,
Petr Jansky,
Mark Lakshmanan ,
Fernando Lanas ,
Lawrence A. Leiter ,
Prem Pais ,
Nana Pogosova ,
Peter J. Raubenheimer ,
Lars Ryden ,
Jonathan E. Shaw
and other authors.
,
Gilles R. Dagenais ,
Alvaro Avezum ,
Jan Basile ,
Ignacio Conget ,
William C. Cushman ,
Petr Jansky,
Mark Lakshmanan ,
Fernando Lanas ,
Lawrence A. Leiter ,
Prem Pais ,
Nana Pogosova ,
Peter J. Raubenheimer ,
Lars Ryden ,
Jonathan E. Shaw
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 